Efficacy of ambruticin analogs in a murine model of coccidioidomycosis

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 10, 2006, Pages 3467-3469

  Shubitz, Lisa F ^a,c   Galgiani, John N ^b,c,d   Tian, Zong Qiang ^e   Zhong, Ziyang ^e   Timmermans, Pieter ^e   Katz, Leonard ^e  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^e KOSAN BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRUTICIN; AMBRUTICIN DERIVATIVE; AMBRUTICIN S; AMPHOTERICIN B; CYCLOPROPANE DERIVATIVE; FLUCONAZOLE; KOSN 2079; KOSN 2089; PYRAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; FEMALE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANTIFUNGAL AGENTS; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; PYRANS; TREATMENT OUTCOME;

EID: 33749519061     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00670-06     Document Type: Article

References (8)

1. Georgopapadakou, N. H. 2001. Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitors. Expert Opin. Investig. Drugs 10:269-280.
2. Knauth, P., and H. Reichenbach. 2000. On the mechanism of action of the myxobacterial fungicide ambruticin. J. Antibiot. (Tokyo) 53:1182-1190.
3. Levine, H. B., S. M. Ringel, and J. M. Cobb. 1978. Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis. Chest 73:202-206.
4. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5. Ringel, S. M. 1978. In vitro and in vivo studies on ambruticin (W7783): new class of antifungal antibiotics. Antimicrob. Agents Chemother. 13:762-769.
6. Shadomy, S., C. J. Utz, and S. White. 1978. In vivo studies with ambruticin in murine histoplasmosis. Antimicrob. Agents Chemother. 14:95-98.
7. Shubitz, L., T. Peng, R. Perrill, J. Simons, K. Orsborn, and J. N. Galgiani. 2002. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA. Infect. Immun. 70:3287-3289.
8. Williams, D. M., J. R. Graybill, and D. J. Drutz. 1979. Experimental chemotherapy of histoplasmosis in nude mice. Am. Rev. Respir. Dis. 120:837-842.